TXHPF yields 44865541.28% · JNJ yields 2.14%● Live data
📍 TXHPF pulled ahead of the other in Year 1
Combined, TXHPF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TXHPF + JNJ for your $10,000?
TechnoPro Holdings, Inc., through its subsidiaries, operates as a technology-focused staffing and services company in Japan and internationally. The company offers various services, including engineer staffing, contract assignment, engineering consulting, domestic nearshore and overseas offshore delivery, job placement, and education and training in the machinery, electrics and electronics, embedded controls, information systems, IT infrastructure, software development and maintenance, civil engineering, production plant, architecture, chemistry, biotechnology, and construction areas. It also provides IT system integration and package products; application development and IT consulting services; assessment, inspection, design, and supervision services of buildings; employment services for people with disabilities; and education and training services for CAD, programming, network construction, web design, PC operation, Microsoft office, etc. In addition, the company offers engineering consultancy and offshore development services; and recruitment process outsourcing services, as well as operates as a recruitment agency. TechnoPro Holdings, Inc. was formerly known as Prompt Holdings, Inc. and changed its name to TechnoPro Holdings, Inc. in April 2013. The company was founded in 1995 and is headquartered in Tokyo, Japan.
Full TXHPF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.